Cidara Therapeutics logo
VerifiedBiotechnology· Founded 2013

Cidara Therapeutics

Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation.

7-day free trial · no credit card

HeadquartersSan Diego, United StatesEmployees55(11 to 50)Annual revenue$50M to <$100MFounded year2013Websitecidara.comLinkedIn profileLinkedIn

Verified contacts

60

available on Kipplo

LinkedIn employees

55

11 to 50 range

Open roles

no listings

Distinct roles

51

indexed titles

Tech stack

6

tools in use

Monthly traffic

organic / mo

Sign up free to see all 60 verified contacts at Cidara Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

60 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Cidara Therapeutics

51 distinct titles indexed · top 10 shown.

  • 3associate scientist
  • 2chief medical officer
  • 2president & ceo
  • 1()
  • 1,,
  • 1accounting manager
  • 1ad, clinical project management & outsourcing
  • 1associate director, clinical data management
  • 1associate director, clinical operations
  • 1associate director, sec reporting
  • +41more titles

Sign up to unlock all 60 contacts at Cidara Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 60 verified contacts at Cidara Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Cidara Therapeutics | Kipplo Discover